This inventor holds 1 USPTO granted patent. Top assignee: Georgia Tech Research Corporation. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Christopher H. Thompson: Innovator in ClC Channel Research
Introduction
Christopher H. Thompson is an accomplished inventor based in Atlanta, GA. He has made significant contributions to the field of pharmaceutical compositions, particularly in the area of ClC channels. His innovative work has led to the development of methods that could potentially treat disorders related to aberrant ClC channel activity.
Latest Patents
Christopher holds a patent titled "Methods for inhibiting CLC-2 channel with GATX2." This patent involves compositions and methods utilizing a scorpion venom peptide that acts as a ligand for ClC channels. One notable aspect of his invention is a pharmaceutical composition containing an effective amount of GaTx2 to inhibit ClC activity. This advancement opens new avenues for treating various disorders linked to ClC channel dysfunction.
Career Highlights
Christopher is affiliated with the Georgia Tech Research Corporation, where he continues to engage in groundbreaking research. His work is characterized by a commitment to advancing scientific knowledge and developing practical applications for his findings.
Collaborations
He has collaborated with notable colleagues, including Neal McCarty and Julia M. Kubanek, who share his passion for innovation and research in the field.
Conclusion
Christopher H. Thompson's contributions to the understanding and treatment of ClC channel-related disorders highlight his role as a leading inventor in the pharmaceutical field. His innovative approaches promise to enhance therapeutic options for patients in need.